Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Karolinska Development’s portfolio company AnaCardio raises SEK 205 million and reports positive Phase 1b data of AC01 STOCKHOLM, SWEDEN January...
Karolinska Development’s portfolio company Umecrine Cognition raises MSEK 23.8 to continue clinical development of golexanolone STOCKHOLM, SWEDEN...
Karolinska Development’s Board of Directors appoints Ben Toogood as new Chairman STOCKHOLM, SWEDEN – December 18, 2024. Karolinska Development AB...
Karolinska Development’s Chairman of the Board resigns at his own request STOCKHOLM, SWEDEN – December 11, 2024. Karolinska Development AB (Nasdaq...
Karolinska Development divests 4,6 million shares in portfolio company OssDsign STOCKHOLM, SWEDEN, December 10, 2024. Karolinska Development AB...
Karolinska Development's portfolio company Modus Therapeutics initiates a phase 2 study with sevuparin for treatment of chronic kidney...
Karolinska Development implements organizational changes for more efficient portfolio management STOCKHOLM, SWEDEN – December 2, 2024. Karolinska...
Karolinska Development's portfolio company Modus Therapeutics secures bridge financing STOCKHOLM, SWEDEN November 19, 2024. Karolinska...
Karolinska Development’s portfolio company Umecrine Cognition presents positive interim data from Phase 1b/2a clinical study STOCKHOLM, SWEDEN –...
Karolinska Development's portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO STOCKHOLM, Sweden, 15 November 2024...
Interim Report - January-September 2024 STOCKHOLM – 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its...
Karolinska Development’s Extraordinary General Meeting 2024 STOCKHOLM, SWEDEN – November 13, 2024. Karolinska Development AB (publ) (“Karolinska...
Karolinska Development’s portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second tranche of investment...
Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine STOCKHOLM...
Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관